Nine Chapters Capital Management’s AngioDynamics ANGO Stock Holding History

Nine Chapters Capital Management’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-13,600	Closed	-$236K	–	67
2017 Q1	$236K	Buy	+13,600	New	+$227K	0.32%	140
2015 Q2	–	Sell	-46,400	Closed	-$825K	–	946
2015 Q1	$825K	Sell	46,400 -2,600	-5%	-$48.3K	0.07%	423
2014 Q4	$931K	Buy	49,000 +13,400	+38%	+$227K	0.08%	351
2014 Q3	$488K	Sell	35,600 -4,600	-11%	-$65.6K	0.04%	525
2014 Q2	$656K	Sell	40,200 -1,600	-4%	-$23.2K	0.05%	461
2014 Q1	$658K	Buy	41,800 +20,200	+94%	+$329K	0.08%	382
2013 Q4	$371K	Buy	+21,600	New	+$332K	0.04%	559

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SAM

Sentinel Asset Management Montpelier, Vermont $868K AUM 45.44% 1-Year Est. Return

Nine Chapters Capital Management's ANGO Position: Q2 2017 in Review

Nine Chapters Capital Management sold out of AngioDynamics (ANGO) in Q2 2017, closing a stake of 13,600 shares — an estimated $236K sold.

Nine Chapters Capital Management first reported a position in ANGO in Q4 2013 and held it in 7 quarters. The position peaked at $931K in Q4 2014. 167 funds tracked by Wall St. Rank hold ANGO as of Q2 2017.

Nine Chapters Capital Management reported no remaining AngioDynamics position as of Q2 2017 after selling out during the quarter.
Nine Chapters Capital Management sold 13,600 AngioDynamics shares in Q2 2017, an estimated $236K.
Nine Chapters Capital Management first reported a position in AngioDynamics in Q4 2013 and held it in 7 quarters.
Nine Chapters Capital Management's AngioDynamics position peaked at $931K in Q4 2014.
167 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2017.

Based on Nine Chapters Capital Management's 13F filing for Q2 2017, filed 31 Jul 2017.